SCHEMBL26074158

SCHEMBL26074158

CCCCCCCCCOc1ccc(-c2ccc(-c3cc(C(=O)OC)c4cc(C(F)(F)F)ccc4n3)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 7/20 0.71
▸ DHODH Q02127 3/20 0.51
▸ PDE10A Q9Y233 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ALPL P05186 1/20 0.45
▸ RUVBL1 Q9Y265 1/20 0.44
▸ RARB P10826 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26074138 1.00 PLA2G2A (0.71) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL26074148 1.00 PLA2G2A (0.71) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL26074143 0.99 PLA2G2A (0.72) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL26074129 0.97 PLA2G2A (0.74) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590300 0.92 DHODH (0.61) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590254 0.92 DHODH (0.61) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590297 0.92 DHODH (0.61) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590299 0.92 DHODH (0.61) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590295 0.91 DHODH (0.62) PLA2G2ADHODHPDE10AKDM4EALDH1A1
SCHEMBL23590250 0.88 DHODH (0.64) PLA2G2ADHODHPDE10AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD PLA2G2A 1679/4885DHODH 1/4885PDE10A 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback